WINT – windtree therapeutics inc (US:NASDAQ)

DELAYED

^$ usd


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

1D

5D

1M

3M

YTD

1Y

3Y

1 Day WINT SPY QQQ SPX

Date

Time

Symbol

Headline

Impact

New Data from the AEROSURF® Phase 2b Clinical Program shows AEROSURF® Appears to Reduce Incidence and Severity of Bronchopulmonary Dysplasia in Preterm Infants with RDS

Windtree Therapeutics Inc (OTCMKTS: WINT) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating.

Live Event:

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff - Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring NQ Founder and Much More

The Smart Way to Ten Minutes Per Day

How to Win Capital and Influence Markets: Analysts Point To Profits (Even When They're Wrong)

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff - Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring NQ Founder and Much More

The Smart Way to Ten Minutes Per Day

How to Win Capital and Influence Markets: Analysts Point To Profits (Even When They're Wrong)